Sinohealth Holdings Limited (HKG:2361)
5.41
-0.09 (-1.64%)
Last updated: Feb 20, 2026, 11:41 AM HKT
Sinohealth Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 392.12 | 403.73 | 396.19 | 356.67 | 324.17 | 202.07 | |
Revenue Growth (YoY) | -4.54% | 1.90% | 11.08% | 10.03% | 60.42% | 13.68% |
Cost of Revenue | 165.61 | 170.53 | 172.72 | 197.56 | 131.53 | 71.87 |
Gross Profit | 226.52 | 233.2 | 223.47 | 159.11 | 192.64 | 130.21 |
Selling, General & Admin | 76.24 | 78.58 | 67.05 | 77.77 | 68.95 | 31.31 |
Research & Development | 68.92 | 64.77 | 61.09 | 60.41 | 53.71 | 39.82 |
Other Operating Expenses | - | - | - | - | 0.02 | 0.11 |
Operating Expenses | 149.79 | 152.69 | 145.75 | 140.86 | 125.19 | 71.93 |
Operating Income | 76.73 | 80.51 | 77.72 | 18.25 | 67.45 | 58.28 |
Interest Expense | -0.53 | -0.62 | -0.64 | -0.41 | -0.53 | -1.22 |
Interest & Investment Income | 25.76 | 26.88 | 27.17 | 15.11 | 6.97 | 12.46 |
Earnings From Equity Investments | - | - | - | - | -0.42 | - |
Currency Exchange Gain (Loss) | 2.57 | 4.86 | 2.29 | 9.53 | 0.04 | 0 |
Other Non Operating Income (Expenses) | -0.82 | 8.46 | 4.19 | 11.44 | 16.1 | 3.51 |
EBT Excluding Unusual Items | 103.71 | 120.09 | 110.73 | 53.92 | 89.61 | 73.03 |
Gain (Loss) on Sale of Investments | - | - | - | 0.04 | 4.82 | 2.99 |
Gain (Loss) on Sale of Assets | - | - | - | 0.52 | - | 0.04 |
Other Unusual Items | 0.05 | 0.06 | 0.01 | - | 1.11 | 0.01 |
Pretax Income | 103.76 | 120.15 | 110.74 | 54.47 | 95.53 | 76.07 |
Income Tax Expense | 9.77 | 8.33 | 9.8 | 0.26 | 23.55 | 10.74 |
Earnings From Continuing Operations | 93.99 | 111.82 | 100.94 | 54.21 | 71.98 | 65.33 |
Minority Interest in Earnings | -0.27 | -1.17 | 1.09 | 1.55 | 6.84 | 2.6 |
Net Income | 93.72 | 110.65 | 102.03 | 55.76 | 78.81 | 67.93 |
Net Income to Common | 93.72 | 110.65 | 102.03 | 55.76 | 78.81 | 67.93 |
Net Income Growth | -2.25% | 8.45% | 82.99% | -29.25% | 16.03% | 21.10% |
Shares Outstanding (Basic) | 405 | 410 | 426 | 411 | 373 | - |
Shares Outstanding (Diluted) | 405 | 410 | 426 | 411 | 373 | - |
Shares Change (YoY) | -3.32% | -3.74% | 3.76% | 10.06% | - | - |
EPS (Basic) | 0.23 | 0.27 | 0.24 | 0.14 | 0.21 | - |
EPS (Diluted) | 0.23 | 0.27 | 0.24 | 0.14 | 0.21 | - |
EPS Growth | 1.11% | 12.65% | 76.35% | -35.72% | - | - |
Free Cash Flow | 78.11 | 89.43 | 75.94 | 29.78 | 58.14 | 60.67 |
Free Cash Flow Per Share | 0.19 | 0.22 | 0.18 | 0.07 | 0.16 | - |
Dividend Per Share | 0.113 | 0.113 | 0.066 | 0.035 | - | - |
Dividend Growth | 71.35% | 71.35% | 86.93% | - | - | - |
Gross Margin | 57.77% | 57.76% | 56.41% | 44.61% | 59.43% | 64.44% |
Operating Margin | 19.57% | 19.94% | 19.62% | 5.12% | 20.81% | 28.84% |
Profit Margin | 23.90% | 27.41% | 25.75% | 15.63% | 24.31% | 33.62% |
Free Cash Flow Margin | 19.92% | 22.15% | 19.17% | 8.35% | 17.94% | 30.02% |
EBITDA | 79.66 | 83.15 | 80.15 | 20.91 | 69.53 | 60.21 |
EBITDA Margin | 20.32% | 20.59% | 20.23% | 5.86% | 21.45% | 29.80% |
D&A For EBITDA | 2.94 | 2.64 | 2.43 | 2.66 | 2.08 | 1.93 |
EBIT | 76.73 | 80.51 | 77.72 | 18.25 | 67.45 | 58.28 |
EBIT Margin | 19.57% | 19.94% | 19.62% | 5.12% | 20.81% | 28.84% |
Effective Tax Rate | 9.42% | 6.93% | 8.85% | 0.48% | 24.65% | 14.12% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.